[123I]VIP receptor scintigraphy in patients with colorectal cancer
1998

Imaging Colorectal Cancer with VIP Scintigraphy

Sample size: 80 publication Evidence: moderate

Author Information

Author(s): M Raderer, A Kurtaran, M Hejnal, F Vorbeck, P Angelberger, W Schefthauer, I Virgolini

Primary Institution: University of Vienna

Hypothesis

Can vasoactive intestinal peptide receptor scintigraphy improve the visualization of colorectal adenocarcinomas?

Conclusion

VIP receptor scintigraphy is a sensitive method for imaging colorectal cancer and can provide valuable information beyond conventional imaging techniques.

Supporting Evidence

  • 87% of primary cancers and 82% of locally relapsing cancers were successfully imaged with VIP.
  • No false positive scans were obtained in patients who had undergone curative resection.
  • VIP scans indicated disease presence before CT in four patients.

Takeaway

Doctors used a special scan to find cancer in people's colons, and it worked really well, helping them see things that regular scans might miss.

Methodology

Eighty patients with colorectal cancer underwent VIP receptor scintigraphy and their results were compared with conventional CT scans.

Limitations

The study did not evaluate the impact of chemotherapy on receptor expression, which could affect scan results.

Participant Demographics

36 women and 44 men with a median age of 67 years.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication